Ervins Development Inc
Community/Retail Pharmacy
411 N Main St, Brownsville
Oregon, 97327-2147
541-466-5112 541-466-5756
Ervins Development Inc is an authorized DME supplier for medicare equipments and products.
Ervins Development Inc is a Community/Retail Pharmacy in Brownsville, Oregon. It is located at 411 N Main St, Brownsville and it's customer support contact number is 541-466-5112. The authorized person of Ervins Development Inc is Jeffrey Shane Harrell who is Owner of the pharmacy and his contact number is 541-466-5112. Active license number of Ervins Development Inc is RP0000140 for Community/Retail Pharmacy in Oregon. Ervins Development Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Ervins Development Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Ervins Development Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Ervins Development Inc |
| Type: | Community/Retail Pharmacy |
| Location: | 411 N Main St, Brownsville, Oregon, 97327-2147 |
| Phone: | 541-466-5112 |
| Fax: | 541-466-5756 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Jeffrey Shane Harrell |
| Position: | Owner |
| Contact Number: | 541-466-5112 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1871660357 |
| NPI Enumeration Date: | 29 Nov, 2006 |
| NPI Last Update On: | 14 Aug, 2025 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ervins Development Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | RP0000140 | Oregon | Primary | |
| Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 2077268 | Other | | Pk |
| 269176 | Medicaid | Oregon | |
| 229450 | Medicaid | Oregon | |
Medicare Enrollment:
Ervins Development Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 7416042650 | O20071002000742 | Ervins Development Inc | PART B SUPPLIER - MASS IMMUNIZATION (ROSTER BILLER ONLY) |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Po Box B, Ilwaco, Washington |
| Zip: | 98624-0167 |
| Phone Number: | -- |
Patients can reach Ervins Development Inc at
411 N Main St, Brownsville, Oregon or can
call on customer care at 541-466-5112.
Comments/ Reviews:
Read all the reviews posted for Ervins Development Inc below. You may also share your own experience with Ervins Development Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.